The mission of the Pan American Journal of Public Health is to serve as an important vehicle for disseminating scientific public health information relevant to the Region of the Americas. The journal aims to strengthen national and local health systems and to bridge the gap between health care and policy-makers, ultimately improving the health of the peoples of the Americas.
The mission of the Pan American Journal of Public Health is to serve as an important vehicle for disseminating scientific public health information relevant to the Region of the Americas. The journal aims to strengthen national and local health systems and to bridge the gap between health care and policy-makers, ultimately improving the health of the peoples of the Americas.
To (i) ascertain stakeholders’ perceptions of the contextual factors and resources necessary to successfully implement the AMORE platform, a tool that provides accessibility assessments for health care services, considering factors such travel time and traffic conditions, and (ii) identify potential barriers to and facilitators for enhancing spatial accessibility to health care services within the Colombian urban context.
Following the advice of an International Health Regulations Emergency Committee of independent experts who met during the afternoon of 14 August to review data presented by experts from the World Health Organization and affected countries, the WHO declared mpox a Public Health Emergency of International Concern. The Committee considered the upsurge of mpox to be a PHEIC, with potential to spread further across countries in Africa and possibly outside the continent.
Medicines are special goods that cover the health needs of the population. In recent decades, the pharmaceutical industry has changed its research and development strategy, shifting its focus from the exploration of medicines for chronic diseases affecting a large part of the population to the search for drugs for rare diseases that affect a small number of people. This lack of a mass consumer base is reflected in a selective offer of a few very high-cost products aimed at certain diseases, which hinders both patient access and financial coverage.
This article analyzes the state of social participation in health in the Region of the Americas, framing it within the regional context and commitments assumed by the Member States of the Pan American Health Organization. It aims to provide regional input to the discussion of a resolution on social participation for universal health coverage, health, and well-being at the 77th World Health Assembly in 2024.
The mission of the Pan American Journal of Public Health is to serve as an important vehicle for disseminating scientific public health information relevant to the Region of the Americas. The journal aims to strengthen national and local health systems and to bridge the gap between health care and policy-makers, ultimately improving the health of the peoples of the Americas.
[Extract] Artificial intelligence (AI) is rapidly transforming numerous sectors and public health is no exception. As a powerful tool for modernizing health systems and services, AI promises to improve health outcomes, enhance efficiency and ensure innovation in public health practices. The G20, representing the world’s largest economies, plays a crucial role in shaping global health policies and driving forward initiatives that leverage AI for public health (1).
The mission of the Pan American Journal of Public Health is to serve as an important vehicle for disseminating scientific public health information relevant to the Region of the Americas. The journal aims to strengthen national and local health systems and to bridge the gap between health care and policy-makers, ultimately improving the health of the peoples of the Americas.
To compare the adequacy, agreement, and acceptability of Papanicolaou testing (cytology) for cervical cancer screening using self-collected samples compared to physician-collected samples in Grenada in the Caribbean. Furthermore, the study identifies the human papillomavirus (HPV) genotypes present among asymptomatic women testing positive for HPV, the etiologic cause of cervical cancer.
